Outbreak of IMP-producing carbapenem-resistant Enterobacter gergoviae among kidney transplant recipients

Journal of Antimicrobial Chemotherapy

Volumn 71, Issue 9, 2016, Pages 2577-2585

  Freire, Maristela Pinheiro ^a   De Oliveira Garcia, Doroti ^b   Cury, Ana Paula ^a   Spadão, Fernanda ^a   Di Gioia, Thais S R ^c   Francisco, Gabriela Rodrigues ^b   Bueno, Maria Fernanda Campagnari ^b   Tomaz, Mariama ^a   De Paula, Flavio Jota ^a   De Faro, Lorena Brito ^c   Piovesan, Affonso C ^a   Rossi, Flavia ^a   Levin, Anna Sara ^a   David Neto, Elias ^a   Nahas, William C ^a   Pierrotti, Ligia Camera ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

^c Dasa Medicina Diagnóstica   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE; CARBAPENEM DERIVATIVE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; CASE CONTROL STUDY; DNA SEQUENCE; ENTEROBACTER; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; EPIDEMIC; FEMALE; GENETICS; GRAFT RECIPIENT; HUMAN; ISOLATION AND PURIFICATION; KIDNEY TRANSPLANTATION; MALE; MICROBIOLOGY; MIDDLE AGED; SECRETION (PROCESS); URINARY TRACT INFECTIONS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CASE-CONTROL STUDIES; DISEASE OUTBREAKS; ENTEROBACTER; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; SEQUENCE ANALYSIS, DNA; TRANSPLANT RECIPIENTS; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 85027529067     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkw165     Document Type: Article

References (38)

1. Linares L, Cervera C, Cofán F et al. Risk factors for infection with extended-spectrum and AmpC b-lactamase-producing gram-negative rods in renal transplantation. Am J Transplant 2008; 8: 1000-5.
2. Satlin MJ, Jenkins SG, Walsh TJ. The global challenge of carbapenemresistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies. Clin Infect Dis 2014; 58: 1274-83.
3. Jacoby GA, Munoz-Price LS. The new b-lactamases. N Engl J Med 2005; 352: 380-91.
4. Munoz-Price LS, Poirel L, Bonomo RA et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 2013; 13: 785-96.
5. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S et al. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008; 52: 1028-33.
6. Gyung Y, Choi SH, Choo EJ et al. Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients. Microb Drug Resist 2005; 11: 165-8.
7. Gasink LB, Edelstein PH, Lautenbach E et al. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol 2009; 30: 1180-5.
8. Tumbarello M, Viale P, Viscoli C et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemaseproducing K. pneumoniae: importance of combination therapy. Clin Infect Dis 2012; 55: 943-50.
9. Cicora F, Mos F, Paz M et al. Infections with blaKPC-2-producing Klebsiella pneumoniae in renal transplant patients: a retrospective study. Transplant Proc 2013; 45: 3389-93.
10. Simkins J, Muggia V, Cohen HW et al. Carbapenem-resistant Klebsiella pneumoniae infections in kidney transplant recipients: a case-control study. Transpl Infect Dis 2014; 16: 775-82.
11. Freire MP, Abdala E, Moura ML et al. Risk factors and outcome of infections with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in kidney transplant recipients. Infection 2015; 43: 315-23.
12. Villa J, Viedma E, Brañas P et al. Multiclonal spread of VIM-1-producing Enterobacter cloacae isolates associated with In624 and In488 integrons located in an IncHI2 plasmid. Int J Antimicrob Agents 2014; 43: 451-5.
13. CDC. Multidrug-resistant Organism & Clostridium difficile Infection (MDRO/CDI) Module. January 2016. http://www.cdc.gov/nhsn/PDFs/pscManual/12pscMDRO-CDADcurrent.pdf.
14. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-second Informational Supplement M100-S22. CLSI, Wayne, PA, USA, 2012.
15. Poirel L, Wash TR, Cuvillier V et al. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 2011; 70: 119-23.
16. CDC. PulseNet. www.cdc.gov/pulsenet.
17. CDC. CDC/NHSN Surveillance Definitions for Specific Types of Infections. January 2016. http://www.cdc.gov/nhsn/PDFs/pscManual/17pscNosInfDef-current.pdf.
18. Chen KJ, Yang KJ, Sun CC et al. Traumatic endophthalmitis caused by Enterococcus raffinosus and Enterobacter gergoviae. J Med Microbiol 2009; 58: 526-8.
19. Satlin MJ, Jenkins SG, Chen L et al. Septic shock caused by Klebsiella pneumoniae carbapenemase-producing Enterobacter gergoviae in a neutropenic patient with leukemia. J Clin Microbiol 2013; 51: 2794-6.
20. Kesieme EB, Kesieme CN, Akpede GO et al. Tension pneumatocele due to Enterobacter gergoviae pneumonia: a case report. Case Rep Med 2012; 2012: 808630.
21. Marcos Sánchez F, Albo Castaño MI, Arbol Linde F et al. Lower respiratory tract infection due to Enterobacter gergoviae. An Med Interna 2005; 22: 553-4.
22. Almeida AC, de Castro KK, Fehlberg LC et al. Carbapenem-resistant Enterobacter gergoviae harbouring blaKPC-2 in Brazil. Int J Antimicrob Agents 2014; 44: 369-70.
23. Ganeswire R, Thong KL, Puthucheary SD. Nosocomial outbreak of Enterobacter gergoviae bacteraemia in a neonatal intensive care unit. J Hosp Infect 2003; 53: 292-6.
24. Martins IS, Moreira BM, Riley LWet al. Outbreak of extended-spectrum b-lactamase-producing Klebsiella pneumoniae infection among renal transplant recipients. J Hosp Infect 2006; 64: 305-8.
25. ZárateMS, Gales AC, Picão RCet al.Outbreak of OXY-2-producing Klebsiella oxytoca in a renal transplant unit. J Clin Microbiol 2008; 46: 2099-101.
26. Kamińska W, Patzer J, Dzierzanowska D. Urinary tract infections caused by endemic multi-resistant Enterobacter cloacae in a dialysis and transplantation unit. J Hosp Infect 2002; 51: 215-20.
27. Gillespie JL, Arnold KE, Noble-Wang J et al. Outbreak of Pseudomonas aeruginosa infections after transrectal ultrasound-guided prostate biopsy. Urology 2007; 69: 912-4.
28. Yardy GW, Cox RA. An outbreak of Pseudomonas aeruginosa infection associated with contaminated urodynamic equipment. J Hosp Infect 2001; 47: 60-3.
29. Kayabas U, Bayraktar M, Otlu B et al. An outbreak of Pseudomonas aeruginosa because of inadequate disinfection procedures in a urology unit: a pulsed-field gel electrophoresis-based epidemiologic study. Am J Infect Control 2008; 36: 33-8.
30. Koo VS, O'Neill P, Elves A. Multidrug-resistant NDM-1 Klebsiella outbreak and infection control in endoscopic urology. BJU Int 2012; 110: E922-6.
31. Nagano N, Shibata N, Saitou Y et al. Nosocomial outbreak of infections by Proteus mirabilis that produces extended-spectrum CTX-M-2 type b-lactamase. J Clin Microbiol 2003; 41: 5530-6.
32. Cagnacci S, Gualco L, Roveta S et al. Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-b-lactamase: first Italian outbreak. J Antimicrob Chemother 2008; 61: 296-300.
33. Peirano G, Lascols C, Hackel M et al. Molecular epidemiology of Enterobacteriaceae that produce VIMs and IMPs from the SMART surveillance program. Diagn Microbiol Infect Dis 2014; 78: 277-81.
34. Hayakawa K, Miyoshi-Akiyama T, Kirikae Tet al. Molecular and epidemiological characterization of IMP-type metallo-b-lactamase-producing Enterobacter cloacae in a large tertiary care hospital in Japan. Antimicrob Agents Chemother 2014; 58: 3441-50.
35. Fehlberg LC, Xavier DE, Peraro PP et al. b-lactam resistance mechanisms in Pseudomonas aeruginosa strains causing bloodstream infections: comparative results between Brazilian and American isolates. Microb Drug Resist 2012; 18: 402-7.
36. Lee JR, Bang H, Dadhania D et al. Independent risk factors for urinary tract infection and for subsequent bacteremia or acute cellular rejection: a single-center report of 1166 kidney allograft recipients. Transplantation 2013; 96: 732-8.
37. Freire MP, Antonopoulos IM, Piovesan AC et al. Amikacin prophylaxis and risk factors for surgical site infection after kidney transplantation. Transplantation 2015; 99: 521-7.
38. Wilson CH, Rix DA, Manas DM. Routine intraoperative ureteric stenting for kidney transplant recipients. Cochrane Database Syst Rev 2013; issue 6: CD004925.